Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antigens, CD34"" wg kryterium: Temat


Tytuł :
Reducing TGF-β1 cooperated with StemRegenin 1 promoted the expansion ex vivo of cord blood CD34 cells by inhibiting AhR signalling.
Autorzy :
Zhu X; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Sun Q; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Tan WS; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Cai H; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Pokaż więcej
Źródło :
Cell proliferation [Cell Prolif] 2021 Mar; Vol. 54 (3), pp. e12999. Date of Electronic Publication: 2021 Jan 31.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD34/*drug effects
Cell Differentiation/*drug effects
Purines/*pharmacology
Signal Transduction/*drug effects
Transforming Growth Factor beta1/*metabolism
Antigens, CD34/analysis ; Antigens, CD34/metabolism ; Cell Cycle/drug effects ; Cell Differentiation/genetics ; Cell Division/drug effects ; Cell Proliferation/drug effects ; Cell Proliferation/physiology ; Humans ; Purines/metabolism ; Signal Transduction/physiology
Czasopismo naukowe
Tytuł :
GMP-grade CD34 selection from HLA-homozygous licensed cord blood units and short-term expansion under European ATMP regulations.
Autorzy :
Liedtke S; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Korschgen L; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Korn J; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Duppers A; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Kogler G; Institute of Transplantation Diagnostics and Cell Therapeutics, José Carreras Stem Cell Bank, University Clinic, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 123-135. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD34*
Immunophenotyping*
Fetal Blood/*immunology
Induced Pluripotent Stem Cells/*immunology
Biological Specimen Banks ; HLA Antigens ; Humans
Czasopismo naukowe
Tytuł :
[CD34+ cell selection methods, quality controls and expected results: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Autorzy :
Calmels B; Centre de thérapie cellulaire, institut Paoli-Calmettes, 13009 Marseille, France.
Gautier É; EFS Île-de-France, unité d'ingénierie et de thérapie cellulaire, 94017 Créteil, France.
Magnani A; Hôpital Necker-Enfants Malades, laboratoire de thérapie cellulaire génique, 75015 Paris, France.
Magrin É; Hôpital Necker-Enfants Malades, laboratoire de thérapie cellulaire génique, 75015 Paris, France.
Mamez AC; Hôpitaux universitaires de Genève, laboratoire de thérapie cellulaire, 1211 Genève, Suisse.
Vaissié A; CHU de Lille, plateforme de biothérapies, 59000 Lille, France.
Yakoub-Agha I; Université de Lille, CHU de Lille, Infinite, U1286, Inserm, 59000 Lille, France.
Baudoux É; CHU de Liège, thérapie cellulaire, 4000 Liège, Belgique. Electronic address: .
Pokaż więcej
Transliterated Title :
Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Źródło :
Bulletin du cancer [Bull Cancer] 2020 Dec; Vol. 107 (12S), pp. S185-S192. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Journal Article; Practice Guideline
MeSH Terms :
Antigens, CD34*
Quality Control*
Hematopoietic Stem Cells/*cytology
Immunomagnetic Separation/*methods
Immunomagnetic Separation/*standards
Cytapheresis ; Graft vs Host Disease/prevention & control ; Hematopoietic Stem Cells/immunology ; Humans ; Pancytopenia/therapy ; Societies, Medical
Czasopismo naukowe
Tytuł :
Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB.
Autorzy :
van Bergen MGJM; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Saes JL; Department of Hematology, Radboudumc, Nijmegen, The Netherlands.; Hemophilia Treatment Center Nijmegen - Eindhoven - Maastricht, Nijmegen, The Netherlands.
Simons A; Department of Human Genetics, Radboudumc, Nijmegen, The Netherlands.
Hebeda KM; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.
Henskens YMC; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.; Central Diagnostic Laboratory, Unit for Hemostasis and Transfusion, Maastricht University Medical Center, Maastricht, The Netherlands.
Barteling W; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Huys E; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Laros-van Gorkom BAP; Department of Hematology, Radboudumc, Nijmegen, The Netherlands.; Hemophilia Treatment Center Nijmegen - Eindhoven - Maastricht, Nijmegen, The Netherlands.
Schols SEM; Department of Hematology, Radboudumc, Nijmegen, The Netherlands.; Hemophilia Treatment Center Nijmegen - Eindhoven - Maastricht, Nijmegen, The Netherlands.
Preijers FW; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Jongmans MCJ; Department of Human Genetics, Radboudumc, Nijmegen, The Netherlands.; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Jansen JH; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
van der Reijden BA; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
American journal of hematology [Am J Hematol] 2020 Jun; Vol. 95 (6), pp. E136-E139. Date of Electronic Publication: 2020 Apr 08.
Typ publikacji :
Case Reports; Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, CD34*/biosynthesis
Antigens, CD34*/genetics
Base Sequence*
Core Binding Factor beta Subunit*/genetics
Core Binding Factor beta Subunit*/metabolism
Gene Expression Regulation*
Sequence Deletion*
Adult ; Female ; Humans
Raport
Tytuł :
MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34 Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia.
Autorzy :
Spinetti G; IRCCS MultiMedica, Milan, Italy .
Sangalli E; IRCCS MultiMedica, Milan, Italy.
Tagliabue E; IRCCS MultiMedica, Milan, Italy.
Maselli D; IRCCS MultiMedica, Milan, Italy.
Colpani O; IRCCS MultiMedica, Milan, Italy.
Ferland-McCollough D; University of Bristol, Bristol, U.K.
Carnelli F; IRCCS MultiMedica, Milan, Italy.
Orlando P; IRCCS MultiMedica, Milan, Italy.
Paccagnella A; Ca Foncello Hospital, Treviso, Italy.
Furlan A; Ca Foncello Hospital, Treviso, Italy.
Stefani PM; Ca Foncello Hospital, Treviso, Italy.
Sambado L; Ca Foncello Hospital, Treviso, Italy.
Sambataro M; Ca Foncello Hospital, Treviso, Italy.
Madeddu P; University of Bristol, Bristol, U.K. .
Pokaż więcej
Źródło :
Diabetes care [Diabetes Care] 2020 Jul; Vol. 43 (7), pp. 1520-1529. Date of Electronic Publication: 2020 May 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/metabolism
Diabetes Mellitus, Type 2*/mortality
Antigens, CD34/*metabolism
Apoptosis Regulatory Proteins/*metabolism
Cardiovascular Diseases/*mortality
Endothelial Cells/*physiology
Ischemia/*diagnosis
MicroRNAs/*metabolism
RNA-Binding Proteins/*metabolism
Adult ; Aged ; Antigens, CD34/blood ; Apoptosis Regulatory Proteins/blood ; Apoptosis Regulatory Proteins/genetics ; Biomarkers/blood ; Biomarkers/metabolism ; Blood Cells/physiology ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/diagnosis ; Case-Control Studies ; Cell Movement/genetics ; Cells, Cultured ; Critical Illness ; Diabetic Angiopathies/diagnosis ; Diabetic Angiopathies/metabolism ; Diabetic Angiopathies/mortality ; Endothelial Cells/metabolism ; Extremities/blood supply ; Female ; Human Umbilical Vein Endothelial Cells ; Humans ; Ischemia/blood ; Ischemia/mortality ; Male ; MicroRNAs/blood ; MicroRNAs/genetics ; Middle Aged ; Predictive Value of Tests ; Prognosis ; RNA-Binding Proteins/blood ; RNA-Binding Proteins/genetics ; Signal Transduction/physiology
Czasopismo naukowe
Tytuł :
Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer.
Autorzy :
Hsieh MJ; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.; Division of Neurology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Chiu TJ; Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung 83301, Taiwan.
Lin YC; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.
Weng CC; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.
Weng YT; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.
Hsiao CC; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 83301, Taiwan.
Cheng KH; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan.; Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Jun 23; Vol. 21 (12). Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Epithelial-Mesenchymal Transition*
Adenomatous Polyposis Coli Protein/*physiology
Antigens, CD34/*metabolism
Carcinoma, Pancreatic Ductal/*secondary
Neoplastic Stem Cells/*pathology
Pancreatic Neoplasms/*pathology
Animals ; Antigens, CD34/genetics ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/metabolism ; Disease Models, Animal ; Disease Progression ; Female ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, SCID ; Mutation ; Neoplastic Stem Cells/metabolism ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/metabolism ; Phenotype ; Signal Transduction
Czasopismo naukowe
Tytuł :
Variability of CD34 Expression in Sinonasal Glomangiopericytoma: A Potential Diagnostic Pitfall.
Autorzy :
Sangoi AR; Departments of Pathology, El Camino Hospital, Mountain View, CA, USA.
Bishop JA; UT Southwestern Medical Center, Clements University Hospital, UH04.239, Dallas, TX, 75390, USA. .
Pokaż więcej
Źródło :
Head and neck pathology [Head Neck Pathol] 2020 Jun; Vol. 14 (2), pp. 459-464. Date of Electronic Publication: 2019 Aug 09.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Antigens, CD34/*analysis
Biomarkers, Tumor/*analysis
Hemangiopericytoma/*diagnosis
Paranasal Sinus Neoplasms/*diagnosis
Adult ; Aged ; Antigens, CD34/biosynthesis ; Diagnosis, Differential ; Female ; Humans ; Immunohistochemistry/methods ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
Autorzy :
Politikos I; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. .
Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Arcila ME; Diagnostic Molecular Pathology, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Barone JC; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maloy MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Naputo KA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ruiz JD; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mazis CM; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Scaradavou A; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.
Avecilla ST; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dahi PB; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Giralt SA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Hsu KC; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Jakubowski AA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Papadopoulos EB; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Sauter CS; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Tamari R; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Ponce DM; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
O'Reilly RJ; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, NY, USA.
Barker JN; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. .
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Mar; Vol. 35 (3), pp. 850-862. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antilymphocyte Serum*
Antigens, CD34/*metabolism
Fetal Blood/*transplantation
Graft vs Host Disease/*prevention & control
Hematologic Neoplasms/*therapy
Hematopoietic Stem Cell Transplantation/*methods
Adult ; Aged ; Clinical Trials, Phase II as Topic ; Donor Selection ; Female ; Follow-Up Studies ; HLA Antigens/immunology ; Haplotypes ; Hematologic Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Prognosis ; Transplantation Conditioning ; Young Adult
Czasopismo naukowe
Tytuł :
Lentivirus-mediated gene therapy for Fabry disease.
Autorzy :
Khan A; Department of Medical Genetics, Metabolics and Pediatrics, Alberta Children's Hospital, Cumming School of Medicine, Research Institute, University of Calgary, Calgary, AB, Canada.
Barber DL; University Health Network, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Huang J; University Health Network, Toronto, ON, Canada.
Rupar CA; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.; Department of Pediatrics, Western University, London, ON, Canada.; Children's Health Research Institute, London, ON, Canada.
Rip JW; Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.
Auray-Blais C; Division of Medical Genetics, Department of Pediatrics, CIUSSS de l'Estrie-CHUS Hospital Fleurimont, Université de Sherbrooke, Sherbrooke, QC, Canada.
Boutin M; Division of Medical Genetics, Department of Pediatrics, CIUSSS de l'Estrie-CHUS Hospital Fleurimont, Université de Sherbrooke, Sherbrooke, QC, Canada.
O'Hoski P; Department of Pathology and Molecular Medicine, McMaster University and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada.
Gargulak K; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
McKillop WM; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Fraser G; Department of Oncology, McMaster University and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada.
Wasim S; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada.
LeMoine K; Nova Scotia Health Authority, QEII Health Sciences Centre, Canadian Fabry Disease Initiative, Nova Scotia Fabry Disease Program, Halifax, NS, Canada.
Jelinski S; Alberta Children's Hospital and Foothills Medical Centre, Calgary, AB, Canada.; Tom Baker Cancer Centre, Alberta Health Services, Calgary, AB, Canada.
Chaudhry A; Departments of Oncology and Medicine, Alberta Blood and Marrow Transplant Program, University of Calgary, Calgary, AB, Canada.
Prokopishyn N; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Morel CF; Fred A. Litwin Family Centre in Genetic Medicine, Department of Medicine, University Health Network, Toronto, ON, Canada.
Couban S; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
Duggan PR; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Fowler DH; Rapa Therapeutics, Rockville, MD, USA.
Keating A; University Health Network, Toronto, ON, Canada.; University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada.
West ML; Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
Foley R; Department of Pathology and Molecular Medicine, McMaster University and Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada.
Medin JA; University Health Network, Toronto, ON, Canada. .; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. .; Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 25; Vol. 12 (1), pp. 1178. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Fabry Disease/*enzymology
Fabry Disease/*therapy
Genetic Therapy/*methods
Lentivirus/*genetics
alpha-Galactosidase/*genetics
alpha-Galactosidase/*therapeutic use
Adult ; Antigens, CD34 ; Bone Marrow Cells ; Fabry Disease/genetics ; Genetic Vectors ; Hematopoietic Stem Cells ; Humans ; Leukocytes ; Male ; Middle Aged ; Trihexosylceramides/blood ; Trihexosylceramides/urine
Czasopismo naukowe
Tytuł :
LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.
Autorzy :
Höpner SS; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Raykova A; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Radpour R; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Amrein MA; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Koller D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Baerlocher GM; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland.
Ochsenbein AF; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. .; Department for BioMedical Research, University of Bern, Bern, Switzerland. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 16; Vol. 12 (1), pp. 1065. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Differentiation*/drug effects
Cell Self Renewal*/drug effects
Cell Self Renewal*/genetics
Hematopoietic Stem Cells/*metabolism
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*pathology
Lymphotoxin beta Receptor/*metabolism
Neoplastic Stem Cells/*pathology
Tumor Necrosis Factor Ligand Superfamily Member 14/*metabolism
Animals ; Antigens, CD34/metabolism ; Cell Cycle/drug effects ; Cell Cycle/genetics ; Cell Proliferation/drug effects ; DNA Damage ; Fluorouracil/pharmacology ; Gene Expression Regulation, Leukemic/drug effects ; Hematopoietic Stem Cells/drug effects ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Mice, Inbred C57BL ; Mice, Knockout ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
[The Predict Significance of ALDH Activity to the Relapse of t(8;21) Acute Myeloid Leukemia Patients at Complete Remission].
Autorzy :
Yang L; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Dao FT; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Wang YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Liu YR; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Jiang H; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Qin YZ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China,E-mail: .
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Feb; Vol. 29 (1), pp. 43-48.
Typ publikacji :
Journal Article
MeSH Terms :
Leukemia, Myeloid, Acute*
ADP-ribosyl Cyclase 1 ; Antigens, CD34 ; Flow Cytometry ; Humans ; Neoplastic Stem Cells ; Prognosis ; Recurrence ; Remission Induction
Czasopismo naukowe
Tytuł :
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement.
Autorzy :
Showalter K; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA .
Spiera R; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.
Magro C; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
Agius P; New York Genome Center, New York, New York, USA.
Martyanov V; Molecular and Systems Biology, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.; Biomedical Data Science, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.
Franks JM; Molecular and Systems Biology, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.; Biomedical Data Science, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.
Sharma R; New York Genome Center, New York, New York, USA.
Geiger H; New York Genome Center, New York, New York, USA.
Wood TA; Molecular and Systems Biology, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.; Biomedical Data Science, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.
Zhang Y; Department of Pathology, Hospital for Special Surgery, New York, New York, USA.
Hale CR; Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, New York, USA.
Finik J; Department of Medicine, Hospital for Special Surgery, New York, New York, USA.
Whitfield ML; Molecular and Systems Biology, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.; Biomedical Data Science, Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.
Orange DE; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.; Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, New York, USA.
Gordon JK; Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Feb; Vol. 80 (2), pp. 228-237. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Machine Learning*
Severity of Illness Index*
Fibroblasts/*physiology
Scleroderma, Diffuse/*genetics
Actins/metabolism ; Adult ; Antigens, CD34/metabolism ; Clinical Trials as Topic ; Collagen/metabolism ; Female ; Forearm ; Gene Expression ; Humans ; Male ; Middle Aged ; Skin/metabolism
Czasopismo naukowe
Tytuł :
Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis.
Autorzy :
Barosi G; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy. .
Rosti V; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Catarsi P; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Villani L; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Abbà C; Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.
Carolei A; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Magrini U; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Gale RP; Centre for Haematology Research, Imperial College London, London, UK.
Massa M; Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy.
Campanelli R; Center for the Study of Myelofibrosis, Laboratory of Biochemistry, Biotechnology and Advanced Diagnostics, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 468-475. Date of Electronic Publication: 2020 Jun 14.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD34/*metabolism
Biomarkers/*metabolism
Blood Cells/*metabolism
Primary Myelofibrosis/*diagnosis
Primary Myelofibrosis/*metabolism
Receptors, CXCR4/*metabolism
Aged ; Case-Control Studies ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Prognosis ; Signal Transduction ; Survival Rate
Czasopismo naukowe
Tytuł :
Optimizing BIO feeding strategy promotes ex vivo expansion of human hematopoietic stem and progenitor cells.
Autorzy :
Sun Q; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
Zhou Y; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
Zhu X; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
Tan WS; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China.
Cai H; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China. Electronic address: .
Pokaż więcej
Źródło :
Journal of bioscience and bioengineering [J Biosci Bioeng] 2021 Feb; Vol. 131 (2), pp. 190-197. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Culture Techniques/*methods
Hematopoietic Stem Cells/*cytology
Hematopoietic Stem Cells/*drug effects
Indoles/*pharmacology
Oximes/*pharmacology
Antigens, CD34/metabolism ; Cells, Cultured ; Dose-Response Relationship, Drug ; Fetal Blood/cytology ; Humans ; Wnt Signaling Pathway/drug effects
Czasopismo naukowe
Tytuł :
Functional properties of human platelets derived in vitro from CD34 cells.
Autorzy :
Do Sacramento V; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Mallo L; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Freund M; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Eckly A; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Hechler B; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Mangin P; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Lanza F; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Gachet C; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France.
Strassel C; Université de Strasbourg, INSERM, EFS-Grand Est, BPPS UMR_S1225, FMTS, F-67000, Strasbourg, France. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jan 22; Vol. 10 (1), pp. 914. Date of Electronic Publication: 2020 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD34*
Hemostasis*
Platelet Aggregation*/drug effects
Platelet Transfusion*
Stem Cells*
Blood Platelets/*physiology
Adenosine Diphosphate/pharmacology ; Animals ; Blood Platelets/metabolism ; Cells, Cultured ; Female ; Glycoproteins/metabolism ; In Vitro Techniques ; Mice, Transgenic ; Peptide Fragments/pharmacology
Czasopismo naukowe
Tytuł :
CD34 and EPCR coordinately enrich functional murine hematopoietic stem cells under normal and inflammatory conditions.
Autorzy :
Rabe JL; Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Hernandez G; Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Chavez JS; Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Mills TS; Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Nerlov C; MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Pietras EM; Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: .
Pokaż więcej
Źródło :
Experimental hematology [Exp Hematol] 2020 Jan; Vol. 81, pp. 1-15.e6. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Cell Proliferation*
Hematopoiesis*
Stress, Physiological*
Antigens, CD34/*metabolism
Endothelial Protein C Receptor/*metabolism
Hematopoietic Stem Cells/*metabolism
Animals ; Antigens, CD34/genetics ; Endothelial Protein C Receptor/genetics ; Hematopoietic Stem Cells/pathology ; Inflammation/chemically induced ; Inflammation/metabolism ; Inflammation/pathology ; Interleukin-1/adverse effects ; Interleukin-1/pharmacology ; Mice ; Mice, Transgenic
Czasopismo naukowe
Tytuł :
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.
Autorzy :
Salas MQ; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Atenafu EG; Department of Biostatistics, Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Bautista MR; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Prem S; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Lam W; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Datt Law A; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Shaibani ZA; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Kim DDH; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Michelis FV; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Lipton JH; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Viswabandya A; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Mattsson J; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Kumar R; Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Pokaż więcej
Źródło :
European journal of haematology [Eur J Haematol] 2020 Jan; Vol. 104 (1), pp. 36-45. Date of Electronic Publication: 2019 Oct 06.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Antigens, CD34*
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Cyclophosphamide/*administration & dosage
Adult ; Aged ; Allografts ; Antilymphocyte Serum/administration & dosage ; Cyclosporine/administration & dosage ; Disease-Free Survival ; Female ; Follow-Up Studies ; Graft vs Host Disease/mortality ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Tytuł :
Single-cell analysis of bone marrow-derived CD34+ cells from children with sickle cell disease and thalassemia.
Autorzy :
Hua P; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Roy N; Department of Haematology, Oxford University National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.; Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
de la Fuente J; Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; and.
Wang G; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.
Thongjuea S; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.
Clark K; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.
Roy A; Department of Paediatrics, University of Oxford, Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom.
Psaila B; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.; Department of Haematology, Oxford University National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.; Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Ashley N; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.
Harrington Y; Department of Paediatrics, St. Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; and.
Nerlov C; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.
Watt SM; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Roberts I; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.; Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Department of Paediatrics, University of Oxford, Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom.
Davies JOJ; Medical Research Council (MRC) Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine and.; Department of Haematology, Oxford University National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.; Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Blood [Blood] 2019 Dec 05; Vol. 134 (23), pp. 2111-2115.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Anemia, Sickle Cell*/genetics
Anemia, Sickle Cell*/metabolism
Anemia, Sickle Cell*/pathology
Antigens, CD34*
Bone Marrow Cells*/metabolism
Bone Marrow Cells*/pathology
Gene Expression Regulation*
Sequence Analysis, RNA*
Single-Cell Analysis*
Thalassemia*/genetics
Thalassemia*/metabolism
Thalassemia*/pathology
Child ; Female ; Humans ; Male
Raport
Tytuł :
Mitochondrial depolarization stimulates vascular repair-relevant functions of CD34 cells via reactive oxygen species-induced nitric oxide generation.
Autorzy :
Joshi S; Department of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, USA.
Jarajapu YPR; Department of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, USA.
Pokaż więcej
Źródło :
British journal of pharmacology [Br J Pharmacol] 2019 Nov; Vol. 176 (22), pp. 4373-4387. Date of Electronic Publication: 2018 Dec 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, CD34*
Diazoxide/*pharmacology
Hematopoietic Stem Cells/*drug effects
Mitochondria/*physiology
Nitric Oxide/*metabolism
Reactive Oxygen Species/*metabolism
Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Cyclic GMP/metabolism ; Hematopoietic Stem Cells/physiology ; Humans
Czasopismo naukowe
Tytuł :
CD34 Hematopoietic Progenitor Cell Subsets Exhibit Differential Ability To Maintain Human Cytomegalovirus Latency and Persistence.
Autorzy :
Crawford LB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Hancock MH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Struthers HM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Yurochko AD; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Goodrum FD; Department of Immunobiology, BIO5 Institute, University of Arizona, Tucson, Arizona, USA.
Nelson JA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2021 Jan 13; Vol. 95 (3). Date of Electronic Publication: 2021 Jan 13 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Host-Pathogen Interactions*
Virus Activation*
Virus Latency*
Antigens, CD34/*metabolism
Cytomegalovirus/*isolation & purification
Cytomegalovirus Infections/*virology
Hematopoietic Stem Cells/*virology
Human Embryonic Stem Cells/*virology
Cells, Cultured ; Cytomegalovirus Infections/metabolism ; Cytomegalovirus Infections/pathology ; Hematopoietic Stem Cells/metabolism ; Human Embryonic Stem Cells/metabolism ; Humans ; Signal Transduction
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies